These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 12848183)

  • 1. Making more sense of "minimal risk".
    Barnbaum D
    IRB; 2002; 24(3):10-3. PubMed ID: 12848183
    [No Abstract]   [Full Text] [Related]  

  • 2. Research involving children: regulations, review boards and reform.
    Gandhi R
    J Health Care Law Policy; 2005; 8(2):264-330. PubMed ID: 16471026
    [No Abstract]   [Full Text] [Related]  

  • 3. Bioethical malpractice: risk and responsibilities in human research.
    Noah BA
    J Health Care Law Policy; 2004; 7(2):175-241. PubMed ID: 15573441
    [No Abstract]   [Full Text] [Related]  

  • 4. Children as research subjects: a proposal to revise the current federal regulations using a moral framework.
    Ross LF
    Stanford Law Pol Rev; 1997; 8(1):159-76. PubMed ID: 16528858
    [No Abstract]   [Full Text] [Related]  

  • 5. Ethical oversight of research in developing countries.
    Kass N; Dawson L; Loyo-Berrios NI
    IRB; 2003; 25(2):1-10. PubMed ID: 12833901
    [No Abstract]   [Full Text] [Related]  

  • 6. A taxonomy of value in clinical research.
    Casarett DJ; Karlawish JH; Moreno JD
    IRB; 2002; 24(6):1-6. PubMed ID: 12683394
    [No Abstract]   [Full Text] [Related]  

  • 7. Time to cut regulations that protect only regulators.
    Nature; 2001 Nov; 414(6862):379. PubMed ID: 11719759
    [No Abstract]   [Full Text] [Related]  

  • 8. Duke's hazards. Did medical experiments put patients needlessly at risk?
    Kaplan S; Brownlee S
    US News World Rep; 1999 May; 126(20):66-8, 70. PubMed ID: 10387890
    [No Abstract]   [Full Text] [Related]  

  • 9. Parents say federal agency helps protect researchers from more than their subjects.
    Maloney DM
    Hum Res Rep; 2000 Oct; 15(10):5-6. PubMed ID: 11913435
    [No Abstract]   [Full Text] [Related]  

  • 10. When do the federal regulations allow placebo-controlled trials in children?
    Miller FG; Wendler D; Wilfond B
    J Pediatr; 2003 Feb; 142(2):102-7. PubMed ID: 12584527
    [No Abstract]   [Full Text] [Related]  

  • 11. How to interpret the federal policy for the protection of human subjects or "Common Rule" (Part A). [for the Working Group of the Human Subjects Research Subcommittee of the National Science and Technology Council].
    Shelton JD
    IRB; 1999; 21(6):6-9. PubMed ID: 11697393
    [No Abstract]   [Full Text] [Related]  

  • 12. Research on humans: what have we learned?
    King NM
    Forum Appl Res Public Policy; 1997; 12(3):132-6. PubMed ID: 12962102
    [No Abstract]   [Full Text] [Related]  

  • 13. Protection of human subjects: first biennial report on the adequacy and uniformity of federal rules and policies, and their implementation for the protection of human subjects in biomedical and behavioral research; Report of the President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research. Department of Health and Human Services. Notice of report for public comment.
    Fed Regist; 1982 Mar; 47(60):13272-305. PubMed ID: 10298467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulating research with decisionally impaired individuals: are we making progress?
    Hoffmann DE; Schwartz J; DeRenzo EG
    DePaul J Health Care Law; 2000; 3(3-4):547-608. PubMed ID: 16594106
    [No Abstract]   [Full Text] [Related]  

  • 15. Rethinking protections for human subjects.
    Gunsalus CK
    Chron High Educ; 2002 Nov; 49(12):B34. PubMed ID: 15287114
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of institutional review boards in protecting human subjects: are we really ready to fix a broken system?
    Beh HG
    Law Psychol Rev; 2002; 26(1):1-47. PubMed ID: 16514756
    [No Abstract]   [Full Text] [Related]  

  • 17. Protecting research subjects--the crisis at Johns Hopkins.
    Steinbrook R
    N Engl J Med; 2002 Feb; 346(9):716-20. PubMed ID: 11870258
    [No Abstract]   [Full Text] [Related]  

  • 18. A review of OHRP compliance oversight letters.
    Borror K; Carome M; McNeilly P; Weil C
    IRB; 2003; 25(5):1-4. PubMed ID: 14870724
    [No Abstract]   [Full Text] [Related]  

  • 19. IRBs, human subjects, and reporting adverse events.
    Maloney DM
    Hum Res Rep; 2005 Nov; 20(11):3. PubMed ID: 16358480
    [No Abstract]   [Full Text] [Related]  

  • 20. Financial conflicts of interest in human subjects research: proposals for a more effective regulatory scheme.
    Jordan KA
    Wash Lee Law Rev; 2003; 60(1):15-109. PubMed ID: 16273696
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.